Nonwoven Fabric Mills (U.S.) — Industry Primer

NAICS 2022 code 313230. A general-audience guide for public-market and private investors.

1. Overview

Nonwoven fabric is cloth made without weaving or knitting. Instead of interlacing yarns, the mill takes plastic pellets or loose fibers and bonds them into a web directly — by heat, chemicals, water jets, or barbed needles. The result is the disposable engineered material behind baby diapers, wet wipes, surgical gowns, N95 mask filters, house wrap, road-bed fabric, coffee filters, and car-interior padding. It is one of the least visible but most pervasive materials in modern life: a "single-use" fabric engineered for one job at the lowest possible cost per square meter.

This is a capital-intensive process-manufacturing business, closer in character to a plastics or paper plant than to a garment maker. A single modern production line costs roughly $30–50 million and runs around the clock, converting polymer resin into fabric "roll goods" sold by the tonne to converters who cut and assemble the finished product.[1] INDA notes that projects can range from a few million dollars to more than $500 million depending on process, scale, and associated infrastructure; Avgol's new high-capacity spunbond line in North Carolina, opened in 2025, represented a $100 million investment.[12][13] Owners make money on a spread — the gap between the selling price of the fabric and the cost of the resin that goes into it — multiplied by how much volume they push through expensive fixed assets. That makes the industry's volume unusually stable (diapers and wipes get bought in any economy) but its margins cyclical, swinging with resin prices, plant utilization, and periodic bouts of overcapacity.

Why an investor cares. Demand is anchored to non-discretionary consumption and long secular tailwinds (aging populations, hygiene adoption, filtration, infrastructure). But it is a low-margin, scale-driven, commodity-leaning field with real cyclicality and, right now, a hangover of idle capacity built during the COVID-19 personal-protective-equipment (PPE) boom.

• Public-market route: essentially one U.S.-listed pure play (Magnera), plus nonwoven operations buried inside diversified giants — DuPont, Kimberly-Clark, Procter & Gamble, Amcor, Owens Corning, and Berkshire Hathaway's Johns Manville. Mativ (MATV) offers exposure to nonwovens and fiber-based media, particularly filtration, healthcare, and industrial applications, though it also owns films, tapes, specialty paper, and packaging businesses.[14] There is no dedicated nonwovens ETF (exchange-traded fund).
• Private route: much of the industry is privately or private-equity-owned (Freudenberg, Fitesa, Ahlstrom, Alkegen, Hollingsworth & Vose). Direct entry means buying or building a specialty mill — high capital, thin commodity margins, better returns in niche filtration/medical.

2. What it is and how it's structured

A nonwoven mill takes fiber or polymer in, and roll goods out. Production normally has three stages: web formation, bonding, and finishing. The core processes an investor should recognize:[2][17]

• Spunbond (spunlaid): melt polypropylene or polyester, spin continuous filaments, lay them into a web, bond with heat. Strong, cheap, the workhorse of hygiene fabric.
• Meltblown: blow molten polymer with hot air into ultra-fine fibers. Weak but excellent at trapping particles — the filter layer in masks, respirators, and air/liquid filtration.
• Spunmelt (SMS): layered spunbond-meltblown-spunbond composites; dominant in North America and Europe for hygiene and medical. Spunmelt plants integrate polymer extrusion, fiber formation, laydown, and bonding in a continuous, high-speed line.
• Spunlace (hydroentanglement): tangle fibers with high-pressure water jets. Soft and cloth-like — wipes, facial masks, medical.
• Needlepunch: mechanically entangle fibers with barbed needles. Heavy-duty — geotextiles, automotive, carpet backing, filtration.
• Airlaid / wetlaid: short fibers (often wood pulp) laid into absorbent webs — premium wipes, feminine care, tabletop, specialty filtration. Airlaid and wetlaid plants look more like specialized pulp-and-paper operations.

Ownership mix. The federal count is 182 firms across 227 establishments.[1][2] The field splits into three tiers: a handful of global scale players running commodity hygiene lines; a middle band of specialty producers (filtration, medical, high-temperature, glass-fiber mats); and many small niche mills. Ownership skews private — family firms and private-equity portfolios — with only a few pure or partial public listings. Fitesa is a privately held, family-controlled subsidiary of Brazil's Évora.[15] Freudenberg is family owned.[16] Ahlstrom is no longer exchange traded following its take-private transaction.[18]

What NAICS 313230 excludes (this matters for sizing). The code counts merchant mills that make nonwoven roll goods. Crucially, NAICS 313230 is an establishment classification, not a census of every nonwoven web made or consumed in the United States — captive nonwoven operations embedded in plants classified by their finished product can fall outside the code.[19] It does not include:

• 325220 – Artificial and Synthetic Fibers and Filaments and the resin suppliers upstream of the mill.
• 313210 / 313220 / 313110 / 313310 – woven and narrow fabric mills, yarn/thread mills, and fabric-finishing mills (the woven and knit textile world).
• 314xxx – Textile Product Mills and other converters that buy roll goods and cut/sew them into finished textile goods.
• 322291 – Sanitary Paper Product Manufacturing – diapers, tampons, and pads assembled from nonwovens plus pulp are counted here, not in 313230.
• 339113 – Surgical Appliance and Supplies – finished gowns, drapes, and masks as medical devices.
• Machinery makers (line builders such as Reifenhäuser, Andritz, Oerlikon) sit in industrial-machinery codes.

3. How big it is

Federal ground-truth figures for NAICS 313230:

Two things stand out. First, revenue per worker near $460,000 (mixing 2022 receipts with 2023 headcount) confirms how capital-intensive and automated this is — machines, not labor, do the work. Second, the industry is not concentrated by antitrust math: the top four firms make about 26.5% of shipments, the top eight 42.3%, the top fifty 87.1%, and the Herfindahl-Hirschman Index (a standard concentration gauge) is just 322.8 — well below the 1,500 threshold regulators treat as "moderately concentrated."[2] A few giants exist, but a long tail of specialty mills keeps the measured field fragmented. (Note: those 2022 figures predate the 2024 Magnera merger described below. The establishment count alone should not be used to infer fragmentation: one company can own numerous plants, and individual process/application niches can be much more concentrated than the aggregate code.)

The undercount caveat. Federal 313230 statistics understate the true U.S. nonwovens economy, for a specific reason: captive production. Consumer-products companies like Kimberly-Clark and Procter & Gamble spin their own nonwovens in-house to feed their diaper and wipe lines, and that output is generally booked under the parent's primary industry (sanitary paper products, code 322291), not under 313230. DuPont's flashspun Tyvek and glass-fiber roofing mats can likewise land in chemical or glass codes. So the roughly $7.7 billion in merchant-mill receipts is the market-sold slice; the total value of nonwoven fabric manufactured in the U.S. is meaningfully larger. For scale, North American nonwovens capacity reached about 5.73 million tonnes in 2024, up by more than 100,000 tonnes for a second consecutive year.[11] The United States represents approximately 88% of North American capacity. North America imported 403,900 tonnes from outside the region and exported 98,700 tonnes in 2022, leaving net imports of 305,200 tonnes — equivalent to 6.5% of regional production.[12] The global nonwovens market was estimated near $44 billion.[4]

4. The investable universe

There is effectively one U.S.-listed pure play. Most exposure comes through diversified companies where nonwovens are one line among many, or through private and private-equity-held firms.

Public companies with nonwoven exposure

Major private and other owners

• Freudenberg (Germany, family-owned) — among the largest nonwoven producers globally, with U.S. plants.[16][21]
• Fitesa (Brazil, Évora/Petropar family) — large U.S. spunmelt hygiene supplier; ~$1.2B nonwovens.[15][21]
• Ahlstrom (Finland; owned by Bain Capital and the Ahlström family following take-private) — filtration, wiping, medical; ~$1.6B nonwovens.[18][21]
• Alkegen (U.S., private-equity-owned; formed from Lydall + Unifrax) — specialty, filtration, high-temperature; ~$750M nonwovens.[21]
• Hollingsworth & Vose (U.S., private) — filtration media.
• Georgia-Pacific (Koch, private), Sandler, TWE Group, Autoneum (automotive), and many niche mills.

Note the recent reshuffle: Glatfelter no longer trades independently — it merged with Berry Global's nonwovens business in November 2024 to form Magnera.[7] Magnera identifies Ahlstrom, Avgol, Mativ, PFNonwovens, Freudenberg, and Fitesa as significant competitors.[9]

5. How the money works

Think of a nonwoven mill as a spread-and-utilization machine.

The spread. Raw material — polypropylene or polyester resin, viscose, or wood pulp — is the single biggest cost, often 60–70% of the total; polypropylene alone carries the majority of polymer volume because it's the cheapest fiber that delivers the softness and water-repellency hygiene products need.[23] Mativ provides a useful cost benchmark: approximately 70% of its cost of goods sold is variable, with raw materials representing roughly 50% of cost of goods sold; about two-thirds of its materials are specified into customers' product designs, which helps explain both customer stickiness and the cost of qualification-driven switching.[24] Owners earn the difference between the fabric's selling price and that resin cost. Most large contracts include resin pass-through clauses that re-index prices to polymer benchmarks — but with a lag. Magnera says increases are generally passed through contractual mechanisms, renewals, and other pricing actions, though profit is exposed when resin, pulp, or energy moves faster than contractual resets.[9] When resin spikes, margins compress until the pass-through catches up; when resin falls, margins temporarily expand. Managing this spread through the cycle is the core operating skill.

Utilization and throughput. Because a line's cost is mostly fixed (depreciation, energy, staffing a 24/7 operation), profitability depends on running near full capacity. Idle time is expensive. A modern spunmelt line runs roughly 15,000–25,000 tonnes a year; keeping it full spreads fixed cost over more kilograms and is the difference between healthy and marginal returns.[1] This is a business of operating leverage — small swings in volume or price move margins a lot. Product changes reduce output through cleaning, threading, trial material, and off-spec production. High-volume hygiene grades favor scale and long campaigns; specialty filtration, medical, and industrial materials can earn better unit margins but require more technical service, qualification work, and shorter runs.

Basis weight and mix. Fabric is priced and specified by grams per square meter (gsm). "Lightweighting" — delivering the same performance with less material — lowers cost per unit and is a genuine competitive edge, especially in commodity hygiene. Product mix matters more: commodity polypropylene hygiene fabric runs a gross margin around 25%,[23] while specialty grades (medical barrier fabric, high-efficiency filtration media, flashspun Tyvek) command far more. The strategic game is shifting mix toward value-added, defensible niches.

What the margins look like. At scale the economics are thin. Magnera, the pure-play leader, generated about $3.2 billion of revenue in fiscal 2025 with roughly $354 million of adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) — an ~11% EBITDA margin — while still posting a net loss, weighed down by merger costs and debt. Its Americas segment produced $241 million of adjusted EBITDA on $1.83 billion of sales, or about 13.1%, though consolidated GAAP operating income was only $5 million reflecting depreciation, integration, and other adjustments.[8][9] That profile — modest margins, heavy assets, leverage — is typical of commodity nonwovens; the specialty end earns more.

Buyer power. Large consumer-products and medical customers wield real purchasing power and can insource, which structurally caps supplier margins. Magnera's largest customer represented approximately 14% of fiscal 2025 sales, and its ten largest represented approximately 42%.[9]

6. What drives demand

The industry is less uniformly defensive than "diapers and wipes" suggests. In 2022, durable end uses represented 51% of North American production by tonnes and disposable uses 49%.[12]

• Hygiene (largest driver, ~32% of demand): baby diapers, feminine care, and adult incontinence.[3][25] Baby diapers face a demographic headwind from falling U.S. birth rates — the final 2024 total fertility rate was a record-low 1,599.5 births per 1,000 women, with 3,628,934 births (up 1% from the 2023 record low) — partly offset by premiumization.[26] Adult incontinence is a structural tailwind as populations age.
• Wipes: baby, personal-care, and disinfecting wipes. Surged in COVID, then normalized; now shaped by flushability rules. Suominen noted the U.S. moist-toilet-tissue category expanded rapidly in 2025.[22]
• Medical: gowns, drapes, sterilization wrap, masks, and respirators — plus continued policy interest in reshoring PPE supply.
• Filtration: air (HVAC, HEPA, cabin), liquid, and industrial media. A bright secular pocket, boosted by cleanroom, data-center, and indoor-air-quality demand. Mativ explicitly aligns its portfolio with cleaner air and water, modern construction, healthcare, and medical wearables.[14]
• Automotive: interior trim, headliners, insulation, and underbody shields; tied to vehicle build rates and lightweighting.
• Construction and geosynthetics: house wrap, roofing mats, and geotextiles for roads, drainage, and erosion control — leveraged to housing starts and federal infrastructure spending.
• Macro backdrop: population growth and rising incomes (mostly overseas), aging demographics, hygiene adoption, and infrastructure investment set the long-run trajectory; the U.S. market is mature and grows in the low single digits.

7. Regulation

Nonwovens are lightly regulated as a material but heavily governed at the end-use:

• Medical: surgical gowns and drapes are FDA-regulated (U.S. Food and Drug Administration) Class II devices with barrier-performance standards (AAMI PB70 levels) requiring premarket notification; lower-risk gowns have different classifications. Respirators require NIOSH (National Institute for Occupational Safety and Health) certification for N95 ratings. A roll-goods mill may not be the finished-device manufacturer, but failure of its material to meet barrier, biocompatibility, flammability, or cleanliness specifications can cause rejection, recalls, or customer loss.[27][28]
• Flushable wipes: the industry association INDA (Association of the Nonwoven Fabrics Industry) maintains GD4 flushability guidelines and "Do Not Flush" labeling standards.[29] Seven states already mandate labeling; the federal WIPPES Act (Wastewater Infrastructure Pollution Prevention and Environmental Safety Act) would set a national "Do Not Flush" labeling standard enforced by the FTC (Federal Trade Commission) — it has advanced through Congress and, as of mid-2026, is at or near enactment.[30]
• Geotextiles: governed by transportation specs such as AASHTO M288 and state DOT requirements.
• Building products: house wrap and roofing mats fall under ICC building codes.
• Environmental and ESG pressures: microplastics and single-use-plastics scrutiny (stricter in the EU than the U.S.), PFAS ("forever chemicals") phase-outs affecting some finishes and filtration media, and a broad sustainability push toward bio-based and recyclable fabrics. EPA's Textile Mills Effluent Guidelines explicitly include nonwoven textile products, and the agency is collecting additional information on possible PFAS discharges to determine whether existing rules remain appropriate — creating both compliance risk for treated materials and a substitution opportunity for suppliers that can provide fluorine-free performance.[31]
• Trade: tariffs on imported nonwovens and periodic PPE-reshoring initiatives shape competitive dynamics against low-cost imports.

8. Competitive dynamics and consolidation

The commodity end is consolidating around scale, while the specialty end stays fragmented. The recent history is a wave of dealmaking: Berry Global rolled up Avintiv/Polymer Group and Providencia; in November 2024 Berry spun its Health, Hygiene and Specialties nonwovens and films business into a merger with Glatfelter to create Magnera (a Reverse Morris Trust; Berry holders got ~90%), instantly the world's largest nonwovens producer at roughly $3.6 billion pro-forma revenue.[7] Then in April 2025, Amcor acquired the remaining Berry Global for about $10.4 billion in stock.[10] In Europe, Ahlstrom and Munksjö merged and were taken private by Bain Capital; in the U.S., Lydall and Unifrax combined to form Alkegen.

Even so, the merchant market is only moderately concentrated (top-four share ~26.5%).[2] Competition runs on cost and scale in commodity hygiene, on softness and quality for premium hygiene customers, and on performance and certification in filtration and medical. Big buyers — Procter & Gamble, Kimberly-Clark, Unicharm — wield real purchasing power and can insource, which structurally caps supplier margins.

A note on capacity measurement. Nameplate capacity is routinely overstated as usable capacity. INDA applies yield factors generally ranging from 85% to 91% and excludes lines incapable of making the specified product. A nominal meltblown or spunbond tonne is not automatically substitutable across filtration, medical, and hygiene grades.[12]

9. Risks

• Spread compression: volatile resin prices can outrun contractual pass-throughs and squeeze margins. Supply outages in polypropylene, specialty pulp, or bicomponent fiber can idle an entire line.
• Overcapacity and imports: the post-COVID meltblown glut is the cautionary tale — global meltblown volume fell from a 2020 peak of ~368,000 tonnes to ~254,000 tonnes by 2023 as PPE demand collapsed, leaving idle lines and price pressure; INDA found machines for sale, lines never installed, and equipment stored for possible future emergencies.[5][6][12] Face masks fell from a third of meltblown output in 2020 toward roughly 6% by 2028.[5] Low-cost Chinese capacity compounds it. Capacity additions are lumpy: a single modern line can materially change supply in a narrow grade, particularly if several producers expand simultaneously.
• Cyclicality: construction, automotive, and industrial end-markets amplify swings.
• Demographic headwind: falling U.S. birth rates pressure diaper volumes.
• Customer concentration and insourcing: a few giant buyers can dictate terms or make fabric themselves.
• Regulatory/ESG: single-use-plastics backlash, microplastics, PFAS, and flushability litigation.
• Leverage: merger-heavy balance sheets (Magnera posted a net loss in FY2025) leave less cushion in a downturn.[8]
• Labor and safety: while labor is not the largest input in high-speed spunmelt plants, specialized operators, electricians, maintenance technicians, process engineers, and quality personnel are difficult to replace. Downtime is expensive. BLS reported a 2024 recordable injury and illness rate of 2.2 cases per 100 full-time workers for nonwoven fabric mills.[32]

10. How to invest and the outlook

Public routes. The only U.S.-listed pure play is Magnera (MAGN) — a small-cap, leveraged, cyclical turnaround story levered directly to nonwoven spreads and utilization. Broader, diluted exposure comes through diversified names where nonwovens are one line: Mativ (MATV) for filtration and healthcare media, DuPont (DD) for Tyvek, Kimberly-Clark (KMB) and Procter & Gamble (PG) for captive hygiene volume, Amcor (AMCR) post-Berry, Owens Corning (OC) and Berkshire Hathaway (BRK.B) (Johns Manville) for glass-mat and building products, Indorama Ventures (IVL) for Avgol hygiene, and Toray (TRYIY) or Suominen (Helsinki) internationally. There is no nonwovens ETF, so index exposure is indirect via materials and consumer-staples funds.

Private routes. Most of the industry is private or private-equity-owned, which is where financial buyers concentrate (Bain in Ahlstrom, private equity in Alkegen; families in Freudenberg and Fitesa). Direct entry means buying or building a specialty mill or rolling up regional converters. The barriers are real — $30–50 million per line and commodity economics — so private returns cluster in specialty niches (filtration, medical barrier, high-temperature) rather than commodity hygiene. Diligence should be performed line by line: process, usable rather than nameplate capacity, age and width, qualified products, customer concentration, contractual pass-through timing, scrap rate, energy intensity, maintenance backlog, environmental history, and replacement cost matter more than a generic nonwovens revenue multiple.

Outlook (forward-looking judgment). Expect low-single-digit volume growth in the mature U.S. market, with global value CAGRs (compound annual growth rates) generally estimated in the mid-single digits.[4] Near term, the key swing factors are the recovery of resin spreads and plant utilization after the COVID overbuild and subsequent destocking, and continued consolidation. The brighter secular pockets are adult incontinence (aging demographics), filtration (data-center, cleanroom, indoor air quality), medical/PPE reshoring, and infrastructure geotextiles. Commodity hygiene, by contrast, is a low-growth scale game where the winners are the lowest-cost, best-utilized operators. Sustainability — bio-based fibers, recyclability, plastic reduction — is becoming both a competitive differentiator and a regulatory axis that will separate leaders from laggards over the next decade. INDA reported that recent North American line additions were increasingly directed toward longer-life applications, rather than exclusively disposable hygiene.[11]

---

Sources

1. U.S. Census Bureau, County Business Patterns 2023, NAICS 313230 (establishments, employment, payroll). https://www.census.gov/programs-surveys/cbp.html
2. U.S. Census Bureau, 2022 Economic Census — Concentration Ratios and Receipts, NAICS 313230. https://www.census.gov/programs-surveys/economic-census.html
3. U.S. Small Business Administration, Table of Small Business Size Standards (2023), NAICS 313230. https://www.sba.gov/document/support-table-size-standards
4. Verified Market Research, "Non-Woven Fabric Market Size, Growth, Trends & Forecast (2025–2033)," 2025. https://www.verifiedmarketresearch.com/product/non-woven-fabric-market/
5. Smithers / Nonwovens News, "US$1bn meltblown industry faces period of readjustment," 2023. https://www.nonwovensnews.com/manufacturing-news/16332-us-1b-meltblown-industry-faces-period-of-readjustment
6. Nonwovens Industry, "Meltblown Faces Challenges," March 2024. https://www.nonwovens-industry.com/issues/2024-03-01/view_features/meltblown-faces-challenges/
7. GlobeNewswire / Magnera, "Magnera Emerges as a New Global Leader… Following the Merger of Berry's Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter," November 4, 2024. https://www.globenewswire.com/news-release/2024/11/04/2974509/0/en/Magnera-Emerges-as-a-New-Global-Leader-in-the-Specialty-Materials-and-Nonwovens-Industry.html
8. Magnera Corporation, "Fourth Quarter and Fiscal Year 2025 Results," 2025 (SEC Form 8-K / investor relations). https://ir.magnera.com/news-releases/news-release-details/magnera-reports-fourth-quarter-and-fiscal-year-results
9. Magnera Corporation, Form 10-K (Fiscal Year 2025). https://www.sec.gov/Archives/edgar/data/41719/000004171925000110/form10k.htm
10. Amcor plc, "Amcor completes combination with Berry Global," April 30, 2025. https://www.amcor.com/media/news/amcor-completes-combination-with-berry-global
11. INDA (Association of the Nonwoven Fabrics Industry), "2025 INDA Supply Report — North American Nonwovens Industry," May 2025. https://www.inda.org/2025-inda-supply-report-shows-north-american-nonwovens-industrys-continued-growth-with-a-focus-on-sustainability/
12. INDA, "2022 Supply Report Executive Summary" (North American capacity, trade data, yield factors). https://www.inda.org/wp-content/uploads/2023/05/Annual22.ExecutiveSummary.pdf
13. Indorama Ventures, "$100M Investment Realized: Avgol Unveils New Production Line," 2025. https://www.indoramaventures.com/en/investor-relations/newsroom/press-releases/2233/100m-investment-realized-avgol-unveils-new-production-line-delivering-high-loft-and-additional-spunbond-nonwoven-capacity
14. Mativ Holdings, Form 10-K (Fiscal Year 2025). https://www.sec.gov/Archives/edgar/data/1000623/000100062326000016/matv-20251231.htm
15. Fitesa, Sustainability Report 2023. https://www.fitesa.com/wp-content/uploads/2024/04/240415_RS23_Fitesa_VF.pdf
16. Freudenberg, "About Us" (company profile). https://www.freudenberg.com/en/company/about-us
17. EDANA, "How are nonwovens made?" (process definitions). https://www.edana.org/nw-related-industry/how-are-nonwovens-made
18. Ahlstrom, "Supreme Court's Decision in the Redemption Proceedings Concerning the Minority Shares," 2025 (ownership history). https://www.ahlstrom.com/Media/releases/press-releases2/2025/supreme-courts-decision-in-the-redemption-proceedings-concerning-the-minority-shares-in-ahlstrom-oyj/
19. U.S. Census Bureau, 2022 Economic Census Questionnaire MC-31322 (industry classification guidance). https://bhs.econ.census.gov/ombpdfs2022/export/2022_MC-31322_mu.pdf
20. Nonwovens Industry, "DuPont — Top Company Profile" (Tyvek/Typar). https://www.nonwovens-industry.com/top-company-profile/dupont/
21. GlobeNewswire, "World Nonwovens Industry Top Ten Producers Review 2024" (Freudenberg, Berry, Ahlstrom, Kimberly-Clark, Glatfelter, Fitesa, DuPont, Toray, Zhejiang Kingsafe, Alkegen), October 29, 2024. https://www.globenewswire.com/news-release/2024/10/29/2970890/28124/en/World-Nonwovens-Industry-Top-Ten-Producers-Review-2024.html
22. Suominen Corporation, "Annual Report 2025" and "President & CEO's Review of the Year 2025." https://www.suominen.fi/newsroom/2026/suominen-has-published-its-annual-report-2025/
23. Mordor Intelligence / Grand View Research, "Polypropylene Non-woven Fabric Market" and nonwoven production-cost economics, 2024–2025. https://www.mordorintelligence.com/industry-reports/polypropylene-non-woven-fabric-market
24. Mativ Holdings, Investor Presentation (filed with SEC). https://www.sec.gov/Archives/edgar/data/1000623/000100062326000027/mativinvestoroverviewmar.htm
25. Grand View Research / MarketsandMarkets, "Nonwoven Fabrics Market — end-use shares (hygiene ~32%)," 2024–2025. https://www.marketsandmarkets.com/Market-Reports/non-woven-fabrics-market-101727296.html
26. CDC National Center for Health Statistics, "Births: Final Data for 2024," National Vital Statistics Reports, Vol. 75, No. 2, 2026. https://www.cdc.gov/nchs/data/nvsr/nvsr75/nvsr75-02.pdf
27. U.S. FDA, "Personal Protective Equipment for Infection Control." https://www.fda.gov/medical-devices/general-hospital-devices-and-supplies/personal-protective-equipment-infection-control
28. U.S. FDA, "Medical Gowns" (guidance and classification). https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/medical-gowns
29. INDA, "Guidelines for Assessing the Flushability of Disposable Nonwoven Products (Edition 4 / GD4)" and Wipes Policy. https://www.inda.org/issues-advocacy/inda-advocacy-center/wipes-policy/
30. U.S. Congress, "WIPPES Act (H.R.2269 / S.1092)," 119th Congress, 2025–2026. https://www.congress.gov/bill/119th-congress/house-bill/2269
31. U.S. EPA, "Textile Mills Effluent Guidelines." https://www.epa.gov/eg/textile-mills-effluent-guidelines
32. U.S. Bureau of Labor Statistics, "Industry Injury and Illness Data — 2024" (Table 1). https://www.bls.gov/web/osh/table-1-industry-rates-national.htm